These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24019535)

  • 1. SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.
    Zhu Q; Kim YH; Wang D; Oh SP; Luo K
    J Cell Biol; 2013 Sep; 202(6):937-50. PubMed ID: 24019535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
    Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
    Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S
    PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts.
    Muñoz-Félix JM; Perretta-Tejedor N; Eleno N; López-Novoa JM; Martínez-Salgado C
    Biochim Biophys Acta; 2014 Jun; 1843(6):1111-22. PubMed ID: 24594380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad7 and protein phosphatase 1alpha are critical determinants in the duration of TGF-beta/ALK1 signaling in endothelial cells.
    Valdimarsdottir G; Goumans MJ; Itoh F; Itoh S; Heldin CH; ten Dijke P
    BMC Cell Biol; 2006 Mar; 7():16. PubMed ID: 16571110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
    Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
    J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
    Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
    J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
    Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
    J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
    Ray BN; Lee NY; How T; Blobe GC
    Carcinogenesis; 2010 Mar; 31(3):435-41. PubMed ID: 20042635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
    Oh SP; Seki T; Goss KA; Imamura T; Yi Y; Donahoe PK; Li L; Miyazono K; ten Dijke P; Kim S; Li E
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2626-31. PubMed ID: 10716993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8.
    van den Bosch MH; Blom AB; van Lent PL; van Beuningen HM; Blaney Davidson EN; van der Kraan PM; van den Berg WB
    Cell Signal; 2014 May; 26(5):951-8. PubMed ID: 24463008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells.
    Mirza SL; Upton PD; Hodgson J; Gräf S; Morrell NW; Dunmore BJ
    Vascul Pharmacol; 2024 Jun; 155():107381. PubMed ID: 38795838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired SMAD1/5 Mechanotransduction and Cx37 (Connexin37) Expression Enable Pathological Vessel Enlargement and Shunting.
    Peacock HM; Tabibian A; Criem N; Caolo V; Hamard L; Deryckere A; Haefliger JA; Kwak BR; Zwijsen A; Jones EAV
    Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):e87-e104. PubMed ID: 32078368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions.
    Itoh F; Itoh S; Adachi T; Ichikawa K; Matsumura Y; Takagi T; Festing M; Watanabe T; Weinstein M; Karlsson S; Kato M
    Blood; 2012 May; 119(22):5320-8. PubMed ID: 22498737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1-Endoglin-Smad1/5/9 signalling.
    Yang C; Sun M; Yang Y; Han Y; Wu X; Wu X; Cao H; Chen L; Lei Y; Hu X; Chen Y; Zeng Z; Li J; Shu X; Yang Z; Lu K; Li Y; Wang X; Yi B
    Eur J Clin Invest; 2024 Aug; 54(8):e14212. PubMed ID: 38591651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro.
    Muñoz-Félix JM; Cuesta C; Perretta-Tejedor N; Subileau M; López-Hernández FJ; López-Novoa JM; Martínez-Salgado C
    Cell Signal; 2016 Sep; 28(9):1252-1261. PubMed ID: 27208502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.